With the current tips for receptor screening, all tumors with 1% or maybe more of positive cells for ER and/or PR need to be regarded as hormone receptor constructive, and also the individuals are thus candidates for endocrine therapy [95].The recommendation is partly depending on new evidence resulting from a systematic evaluation of the Cochrane